Man-made salt marshes have less biodiversity than similar naturally occurring habitats, and so are failing to meet European regulations.
DISEASE

Cells turn back clock in diabetes
In type 2 diabetes, the pancreas's β cells stop making insulin because they revert to progenitor cells, rather than because they die, as has been thought.
A team led by Domenico Accili at Columbia University in New York studied mice lacking the Foxo1 gene, which is involved in cell specialization or differentiation, in their β cells. The animals produced fewer β cells and developed high bloodsugar levels. Moreover, the authors found that the β cells reverted back to endocrine progenitor cells, which are unable to make insulin. Mice in two other models of diabetes also produced such de-differentiated β cells.
Turning these stem cells back into β cells could be a way to treat type 2 diabetes, the authors suggest. 
NANOTECHNOLOGY
Pulsating tubes act as pumps
Nanometre-scale tubules made of self-assembled molecules have been designed to expand DRUG DEVELOPMENT Fragile-X drug in humans and mice A drug called arbaclofen has shown potential for relieving symptoms of fragile X syndrome -a genetic disease that causes intellectual disability and autismaccording to a clinical and an animal study published backto-back.
Fragile X syndrome is caused by a faulty gene, which leads to excessive protein synthesis at neuronal connections, or synapses, in the brain, and to exaggerated excitatory neurotransmission. Two teams led by scientists from Seaside Therapeutics in Cambridge, Massachusetts, investigated whether arbaclofen -which promotes inhibitory neurotransmission by activating GABA b receptors -could mitigate symptoms.
Paul Wang and his colleagues ran a placebocontrolled clinical trial in 63 people with fragile X. They found no effect on irritability, but social function improved in 27 people who had severe social impairment.
In a study of mice with the condition, Aileen Healy and her colleagues found and contract with changing temperature, pumping molecules out of their interior.
Nanotubes are normally too rigid to allow major structural changes, thanks to the bonds that hold their shape. Myongsoo Lee at Seoul National University and his colleagues created pulsating nanotubules from bent carbon-based chains that stack together in water. The 'arms' of the chains overlap to form staggered that the drug corrected the excessive protein synthesis and associated synaptic abnormalities. 
RESEARCH HIGHLIGHTS
Selections from the scientific literature
